These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18695674)

  • 1. Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL.
    Leeman JR; Weniger MA; Barth TF; Gilmore TD
    Oncogene; 2008 Dec; 27(53):6770-81. PubMed ID: 18695674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
    Fan Y; Gélinas C
    Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient malignant transformation of chicken spleen cells.
    Epinat JC; Dvorin EL; Gilmore TD
    Oncogene; 2000 Jun; 19(28):3131-7. PubMed ID: 10918567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
    Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2003 Oct; 22(44):6928-36. PubMed ID: 14534540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells.
    Kalaitzidis D; Ok J; Sulak L; Starczynowski DT; Gilmore TD
    Oncogene; 2004 Sep; 23(45):7580-7. PubMed ID: 15326488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.
    Rayet B; Fan Y; Gélinas C
    Mol Cell Biol; 2003 Mar; 23(5):1520-33. PubMed ID: 12588973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.
    Dutta J; Fan G; Gélinas C
    J Virol; 2008 Nov; 82(21):10792-802. PubMed ID: 18753212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins.
    Gupta N; Delrow J; Drawid A; Sengupta AM; Fan G; Gélinas C
    Cancer Res; 2008 Feb; 68(3):808-14. PubMed ID: 18245482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain.
    Sarkar S; Gilmore TD
    Oncogene; 1993 Aug; 8(8):2245-52. PubMed ID: 8336947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S; Capobianco AJ; Gilmore TD
    Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.
    Mosialos G; Hamer P; Capobianco AJ; Laursen RA; Gilmore TD
    Mol Cell Biol; 1991 Dec; 11(12):5867-77. PubMed ID: 1944267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transactivation of gene expression by nuclear and cytoplasmic rel proteins.
    Hannink M; Temin HM
    Mol Cell Biol; 1989 Oct; 9(10):4323-36. PubMed ID: 2555689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.
    Chen C; Agnès F; Gélinas C
    Mol Cell Biol; 1999 Jan; 19(1):307-16. PubMed ID: 9858554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new transcript splice variant of the human glucocorticoid receptor: identification and tissue distribution of hGR Delta 313-338, an alternative exon 2 transactivation domain isoform.
    Turner JD; Schote AB; Keipes M; Muller CP
    Ann N Y Acad Sci; 2007 Jan; 1095():334-41. PubMed ID: 17404046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins.
    Gilmore TD; Gélinas C
    Methods Mol Biol; 2015; 1280():427-46. PubMed ID: 25736765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.
    Garbati MR; Alço G; Gilmore TD
    Cancer Lett; 2010 May; 291(2):237-45. PubMed ID: 19948376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three mutations in v-Rel render it resistant to cleavage by cell-death protease caspase-3.
    Barkett M; Dooher JE; Lemonnier L; Simmons L; Scarpati JN; Wang Y; Gilmore TD
    Biochim Biophys Acta; 2001 Apr; 1526(1):25-36. PubMed ID: 11287119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.